» Articles » PMID: 33061807

Lnc-MCEI Mediated the Chemosensitivity of Esophageal Squamous Cell Carcinoma Via MiR-6759-5p to Competitively Regulate IGF2

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2020 Oct 16
PMID 33061807
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Large amounts of long non-coding RNAs (lncRNAs) have been annotated whereas most of them have not been functionally characterized. Here we identified lncRNA ENST00000441932 as an oncogenic lncRNA in esophageal squamous cell carcinoma (ESCC) and named lnc-MCEI (lncRNA mediated the chemosensitivity of ESCC by regulating IGF2). What's more, the effect of lnc-MCEI on the chemosensitivity of ESCC was further evaluated. Bioinformatics analysis demonstrated that lnc-MCEI was involved in the tumorigenesis of ESCC and lnc-MCEI levels were significantly increased in ESCC cells and tissues. Additionally, lnc-MCEI knockdown retarded cell proliferation, colony formation of ESCC cells, but induced cell apoptosis. Moreover, lnc-MCEI knockdown significantly improved the chemosensitivity of ESCC to cisplatin (DDP) both and . Further mechanisms disclosed that lnc-MCEI functioned as a competing endogenous RNA (ceRNA) via sponging miR-6759-5p and IGF2 was a target of miR-6759-5p. Meanwhile, we found that IGF2 suppressed chemosensitivity of ESCC cells via PI3K/AKT pathway. These data suggested that lnc-MCEI was an oncogenic lncRNA and lnc-MCEI knockdown enhanced chemosensitivity of ESCC cells to cisplatin by targeting miR-6759-5p /IGF2/PI3K/AKT axis.

Citing Articles

The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors.

Li P, Ma X, Gu X Front Cell Dev Biol. 2024; 12:1442193.

PMID: 39161590 PMC: 11330846. DOI: 10.3389/fcell.2024.1442193.


LncRNA HEIH/miR-4500/IGF2BP1/c-Myc Feedback Loop Accelerates Bladder Cancer Cell Growth and Stemness.

Guo B, Zhao D, Feng J, Liu Y Bladder Cancer. 2024; 8(3):255-267.

PMID: 38993687 PMC: 11181846. DOI: 10.3233/BLC-211544.


Roles of long non‑coding RNAs in esophageal cell squamous carcinoma (Review).

Yan Q, Wong W, Gong L, Yang J, Liang D, Chin K Int J Mol Med. 2024; 54(2).

PMID: 38963019 PMC: 11232667. DOI: 10.3892/ijmm.2024.5396.


NEK2 promotes the migration, invasion, proliferation of ESCC and mediates ESCC immunotherapy.

Gu S, Yasen Y, Wang M, Huang B, Zhou Y, Wang W Heliyon. 2024; 10(9):e29682.

PMID: 38707418 PMC: 11066149. DOI: 10.1016/j.heliyon.2024.e29682.


The Role of Long Noncoding RNAs (lncRNAs) in Esophageal Cancer Therapy Resistance and Metastasis.

Weng Z, Hsu S, Wang H, Chen K, Lee P, Chiu C Biomedicines. 2024; 12(3).

PMID: 38540273 PMC: 10967897. DOI: 10.3390/biomedicines12030660.


References
1.
Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T . IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma. Ann Surg Oncol. 2013; 21(4):1166-74. DOI: 10.1245/s10434-013-3414-7. View

2.
Wang Y, Liu J, Yang J, Yu X, Chen Z, Chen Y . Lnc-UCID Promotes G1/S Transition and Hepatoma Growth by Preventing DHX9-Mediated CDK6 Down-regulation. Hepatology. 2019; 70(1):259-275. PMC: 6618099. DOI: 10.1002/hep.30613. View

3.
Zaidi N, Kelly R . The management of localized esophageal squamous cell carcinoma: Western approach. Chin Clin Oncol. 2017; 6(5):46. DOI: 10.21037/cco.2017.07.07. View

4.
Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X . Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Mol Cancer. 2017; 16(1):150. PMC: 5577767. DOI: 10.1186/s12943-017-0715-7. View

5.
Kashyap M, Abdel-Rahman O . Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma. Mol Cancer. 2018; 17(1):54. PMC: 5817798. DOI: 10.1186/s12943-018-0790-4. View